Theriva Biologics Publishes Phase 1 Trial Data for Cancer Treatment

AI-generated NewsSnap summary based on source reporting.
Published: 2026-06-11
Category: business
Source: SEC.gov
Original source

Theriva Biologics has announced the publication of its Phase 1 clinical trial results for VCN-01, a treatment for Head & Neck Squamous Cell Carcinoma. The findings were published in Clinical Cancer Research, marking a step in the development of this potential therapy.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai